Ultragenyx Pharmaceutical shares owned by Raymond James & Associates
Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by Raymond James & Associates
from 13F filings
Historical chart of Raymond James & Associates investment in Ultragenyx Pharmaceutical
Tip: Access up to 7 years of quarterly data
All positions including Ultragenyx Pharmaceutical held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Ultragenyx Pharmaceutical by Raymond James & Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $958k | 21k | 46.69 |
| 2023-12-31 | $706k | 15k | 47.82 |
| 2023-09-30 | $633k | 18k | 35.65 |
| 2023-06-30 | $1.2M | 27k | 46.13 |
| 2023-03-31 | $965k | 24k | 40.10 |
| 2022-12-31 | $919k | 20k | 46.33 |
| 2022-09-30 | $449k | 11k | 41.41 |
| 2022-06-30 | $806k | 14k | 59.68 |
| 2022-03-31 | $1.0M | 14k | 72.61 |
| 2021-12-31 | $800k | 9.5k | 84.13 |
| 2021-09-30 | $887k | 9.8k | 90.16 |
| 2021-06-30 | $900k | 9.4k | 95.33 |
| 2021-03-31 | $1.8M | 16k | 113.88 |
| 2020-12-31 | $1.3M | 9.7k | 138.47 |
| 2020-09-30 | $503k | 6.1k | 82.24 |
| 2020-06-30 | $457k | 5.8k | 78.28 |
| 2018-03-31 | $267k | 5.2k | 51.04 |
| 2017-12-31 | $295k | 6.4k | 46.30 |
| 2017-09-30 | $386k | 7.2k | 53.26 |
| 2017-06-30 | $442k | 7.1k | 62.17 |
| 2017-03-31 | $359k | 5.3k | 67.76 |
| 2016-12-31 | $385k | 5.5k | 70.32 |
| 2016-09-30 | $843k | 12k | 70.97 |
| 2016-06-30 | $232k | 4.7k | 48.85 |
| 2016-03-31 | $696k | 11k | 63.32 |
More positions owned by Raymond James & Associates
Home Depot (HD)
View all positions for Raymond James & Associates